How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Purdue’s Presidential Lecture Series is a cornerstone of the intellectually vibrant community of scholars on our campus. Universities are places where ideas compete and curious minds gather, ...

“The people building AI earnestly believe that it could kill us all by the end of the decade.” That blunt admission from former Anthropic employee Jacob Coxon made waves Tuesday, as the just-quit ...

The Department of Landscape Architecture & Regional Planning's Zube Lecture Series invites leading scholars and practitioners from around the world to give weekly talks on major topics in landscape ...

ACS Interactions brings programs and sessions on innovation, skill development, and scientific discussions. This diverse program features curated scientific discussions, thought-provoking leadership ...

Looks like Kenny and Armando and Niles and Matilda aren’t the only TLC alums joining the 90 Day Fiancé: The Other Way Season 8 cast! On October 4, a brand-new season of 90 Day Fiancé: The Other Way ...

Find the course descriptions you're looking for, all in one place. You have decisions to make. Important ones. So take your time. Browse through the catalogs below that describe our undergraduate ...

Mark Carney, former Governor of the Bank of England, argues that changing attitudes to value and the marketplace have contributed to a trio of crises: credit, Covid and climate. Why have financial ...

In her 2024 Reith Lectures, Dr Gwen Adshead addresses the most pertinent questions that she has faced in her work as a forensic psychiatrist in secure psychiatric units and prisons Forensic ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...